Novartis Fellowships

Novartis Institutes for Biomedical Research – Fellowships in Early Clinical Development

The Novartis Institutes for BioMedical Research (NIBR) in conjunction with MCPHS University offers 5 unique post-PharmD Fellowships in early clinical drug development:

  • Clinical Sciences and Innovation (CS&I)
  • Biomarker Development (BMD)
  • Translational Clinical Oncology (TCO)
  • Clinical Quality Assurance (QA)
  • Regulatory Affairs (RA)

These Fellowships are two-year post-PharmD Fellowship programs designed to provide highly motivated candidates the unique opportunity to gain practical experience in early clinical drug development at NIBR. These programs also present the opportunity to increase academic skills in collaboration with MCPHS University. Collectively, the NIBR Fellowships are designed to provide a comprehensive, high-quality postdoctoral experience.

NIBR Overview

NIBR is the global pharmaceutical research organization for Novartis committed to discovering innovative medicines to treat diseases with high unmet medical need. With more than 6,000 scientists and physicians around the world, our open and entrepreneurial culture encourages collaboration as we work to push the boundaries of science to change the practice of medicine.

The culture of our organization is firmly grounded in its values outlining what is expected of each associate. Our six core values serve as the foundation to guide our actions: Innovation, Quality, Collaboration, Performance, Courage, and Integrity. A large part of our culture is helping associates develop. Please see the NIBR Website for additional information.

Fellowship Objectives

The Fellowship is comprised of the NIBR component and MCPHS University component. Fellows will spend the majority of their time at NIBR obtaining real world clinical trial experience with a smaller portion of time dedicated to MCPHS University activities. Over the course of the Fellowship, the Fellows will:

  • Learn the phases of drug development, regulatory process requirements, and clinical regulations such as current good clinical practice (cGCP) requirements and International Conference on Harmonization (ICH) guidelines
  • Gain practical experience in the drug development process as an integral part of a development team working on actual early phase development clinical studies in various phases from start-up through close-out
  • Utilize clinical and scientific knowledge to understand the design and conduct of early phase clinical studies
  • Participate in didactic seminars, workshops, and group forums related to clinical research
  • Expand technical writing proficiency of clinical documents such as study protocols and reports
  • Strengthen presentation skills at internal meetings and at national conferences

MCPHS University

Through MCPHS University, Fellows will have the opportunity to gain teaching and research experience in an academic setting. As an adjunct instructor at MCPHS University, Fellows may have the opportunity to:

  • Develop, coordinate, and teach courses
  • Create and publish scholarly research and/or review articles
  • Present data at scientific and clinical meetings
  • Partake in professional development seminars with other Fellows
  • Participate in the New England Postgraduate Pharmacy Teaching and Learning Seminar

Program Design

  • Duration: Two years
  • Location: NIBR (Cambridge, MA) and MCPHS University (Boston, MA or Worcester, MA)
  • Start date: First week in July

Programs Available:

  • Clinical Sciences and Innovation (CS&I) – General Medicine
  • Biomarker Development (BMD) – Biomarker focus
  • Translational Clinical Oncology (TCO) – Oncology focus
  • Clinical Quality Assurance (QA) – Clinical Quality focus
  • Regulatory Affairs (RA) – General Medicine, Translational Clinical Oncology, and Companion Diagnostics focus

Eligibility

Fellows will be selected on a nationally competitive basis. Applicants must have a PharmD from an ACPE accredited college of pharmacy prior to the start date of the fellowship on July 1. Candidates must have strong written and verbal communication skills and an interest in pursuing a career in the biopharmaceutical industry. All candidates must have authorization to work in the United States throughout the duration of the two-year fellowship. No visa sponsorship will be provided.

Compensation

Fellows will receive a competitive stipend and benefit package including comprehensive health insurance from MCPHS University. Attendance to one or more professional meetings, conferences, or workshops will be sponsored by NIBR.

Application Procedure

Participation in the Personnel Placement Service (PPS) at the ASHP Midyear Clinical Meeting is strongly encouraged, but not required. Candidates are encouraged to request a preliminary interview at the ASHP Midyear Meeting through the PPS website.

Before ASHP Midyear Clinical Meeting

Interested individuals should request an interview through the PPS portal. In order to be considered for an interview at Midyear, the following should be submitted through the PPS portal:

  • Letter of intent stating your interest in the NIBR Fellowship and working with clinical trials
  • A current CV

After ASHP Midyear Clinical Meeting

The formal application materials below must be received by December 20th. Submit via the on-line portal.

  • Letter of intent
  • Updated CV
  • 3 Letters of Recommendations
  • Unofficial college transcript

Onsite Interviews

  • Top candidates will be invited for NIBR onsite interviews in Cambridge, MA

Please see our brochure for additional details.

For more information, please contact: pharmd.fellowships@novartis.com. Please specify which program you are pursuing in the subject line.